Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 237 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLECAINIDE | 50MG | TABLET | Resolved | 2021-01-08 | 2021-01-20 | 131160 |
| APO-HYDROMORPHONE | 8MG | TABLET | Resolved | 2021-01-08 | 2021-03-01 | 131163 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
| APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2021-01-08 | 2021-01-20 | 131176 |
| APO-ALFUZOSIN | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-01-20 | 131809 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
| APO-CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-18 | 2021-02-09 | 131815 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-18 | 2021-03-09 | 131870 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2021-01-18 | 2021-02-26 | 131875 |
| APO-METHYLPHENIDATE SR | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-18 | 2021-02-10 | 131880 |
| APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-04-15 | 131883 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2021-01-18 | 2021-01-19 | 131886 |
| APO-SUMATRIPTAN | 100MG | TABLET | Resolved | 2021-01-18 | 2021-02-05 | 131889 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Resolved | 2021-01-18 | 2021-01-19 | 131892 |
| APO-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-01-22 | 2021-01-29 | 132349 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-01-22 | 2021-01-27 | 132355 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2021-01-22 | 2021-02-11 | 132358 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Resolved | 2021-01-22 | 2022-02-10 | 132363 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2021-01-29 | 2021-05-26 | 132703 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2021-01-29 | 2021-03-24 | 132706 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |
| IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-07-22 | 71439 |
| IBUPROFEN CAPLETS | 400MG | TABLET | Discontinued | 2019-01-07 | 2019-07-13 | 71451 |
| APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |
| APO-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78269 |
| APO-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-03-11 | 2019-09-20 | 78272 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
| APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
| APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
| APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 |